Skip to main content
. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736

Fig. 1.

Fig. 1

a. Comparative analysis of the prevalence of resistance to 13 antipseudomonal agents in 2017 and 2022 Spanish nation-wide studies. b. Comparative analysis of the prevalence of resistance among ICU and nonICU isolates from the 2022 study. c. Comparative analysis of the prevalence of resistance in ICU isolates from 2017 to 2022 studies. In the case of meropenem, “I” (susceptible increased exposure) isolates were also represented (in a lighter tone and with numbers between brackets) in addition to resistant isolates for reference since these isolates show low level resistance. Statistical significance (Chi-square, X2) indicated (∗∗∗p < 0.0001; ∗∗p < 0.01; ∗p < 0.05).